Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -97.64% is 97% above its 5-year average of -3639.02%, near the high end of its 5-year range (-40632.84%–-13.36%).
18.17% above its 12-month average of -119.32%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -68.43%.
NET PROFIT MARGIN
-97.64%
NET PROFIT MARGIN AVG TTM
-119.32%
NET PROFIT MARGIN AVG 3Y
-2935.92%
NET PROFIT MARGIN AVG 5Y
-3639.02%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.17%
CURRENT VS 3Y AVG
+96.67%
CURRENT VS 5Y AVG
+97.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 373 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Net Profit Margin
-97.64%
TTM Avg
-119.32%
3Y Avg
-2935.92%
5Y Avg
-3639.02%
Market Cap
$12.89B
Net Profit Margin
3.99%
TTM Avg
6.17%
3Y Avg
6.60%
5Y Avg
6.82%
Market Cap
$13.19B
Net Profit Margin
6.61%
TTM Avg
16.89%
3Y Avg
20.26%
5Y Avg
23.62%
Market Cap
$12.52B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$12.17B
Net Profit Margin
2.05%
TTM Avg
0.66%
3Y Avg
-0.28%
5Y Avg
0.00%
Market Cap
$12.00B
Net Profit Margin
10.01%
TTM Avg
9.01%
3Y Avg
7.89%
5Y Avg
8.30%
Market Cap
$14.16B
Net Profit Margin
71.08%
TTM Avg
-67.82%
3Y Avg
-363.95%
5Y Avg
-2068.81%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | -97.64% | -119.32% | -2935.92% | -3639.02% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.99% | 6.17% | 6.60% | 6.82% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 6.61% | 16.89% | 20.26% | 23.62% |
| Baxter International Inc. (BAX)vs › | $12.52B | -9.27% | -7.30% | -3.29% | 1.14% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.67% | 6.92% | 5.54% | 3.35% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 2.05% | 0.66% | -0.28% | 0.00% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 10.01% | 9.01% | 7.89% | 8.30% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 71.08% | -67.82% | -363.95% | -2068.81% |
| DaVita Inc. (DVA)vs › | $11.47B | 6.05% | 6.39% | 5.83% | 6.41% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 14.97% | 10.50% | 15.15% | 16.71% |
Operating Margin
-113.3%
Net Profit Margin
-97.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -68.43% |
| 2026-03-31 | -84.33% |
| 2025-12-31 | -127.93% |
| 2025-09-30 | -151.40% |
| 2025-06-30 | -164.52% |
| 2025-03-31 | -143.55% |
| 2024-12-31 | -4506.12% |
| 2024-09-30 | -5931.19% |
| 2024-06-30 | -3388.19% |
| 2024-03-31 | -16.68% |
| 2023-12-31 | -9635.99% |
| 2023-09-30 | -4326.55% |
| 2023-06-30 | -9622.12% |
| 2023-03-31 | -7675.58% |
| 2022-12-31 | -7357.81% |
| 2022-09-30 | -40632.84% |
| 2022-06-30 | -13.36% |
| 2022-03-31 | -11593.68% |
| 2021-12-31 | -1142.15% |
| 2021-09-30 | -6652.52% |
| 2021-06-30 | -178.34% |
| 2021-03-31 | -35298.48% |
| 2020-12-31 | -98345.08% |
| 2020-09-30 | -1425.61% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -531.57% |
| 2019-09-30 | -224.30% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
